Tactile Systems Technology Inc. (TCMD)
NASDAQ: TCMDHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
TCMD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $573.48M
- P/E (TTM)
- 24.85
- Forward P/E
- 17.41
- EPS (TTM)
- $1.03
- Dividend yield
- None
- 52-week range
- 20.53 – 37.77
- Day range
- 25.31 – 26.29
- Volume / Avg
- 239.29K / 248.63K
- Beta
- —
- Shares outstanding
- 22.40M
52-week range
TCMD stock today
On Nov 20, TCMD ended the session at $25.60, shedding $0.39 (1.50%), versus the S&P 500's 3.70% decline. At this level, TCMD sits in the middle of its 52-week range of $20.53 to $37.77: 32.2% below the high, set on Feb 18, 2026 and 24.7% above the low. TCMD is down 11.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 0.4%.
Tactile Systems Technology trades at 24.9x its trailing twelve-month earnings per share of $1.03. Its forward P/E of 17.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Tactile Systems Technology
Company profileTactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Ms. Sheri Louise Dodd
- Headquarters
- Minneapolis, MN
- Employees
- 1,086
- IPO year
- 2016
- Website
- tactilemedical.com
Financial highlights
Full financialsIn fiscal 2025, Tactile Systems Technology generated $329.5 million in revenue, up 12.5% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $19.1 million (+12.5% year over year), for a net margin of 5.8% versus a median of -0.3% in the prior 5 years. Gross margin was 75.9% (up from 74.0%) and operating margin 8.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $329.52M | $292.98M | $274.42M | $246.78M | $208.06M |
| Growth | +12.47% | +6.76% | +11.20% | +18.61% | +11.18% |
| Net income | $19.09M | $16.96M | $28.52M | $-17.87M | $-11.81M |
| EPS (diluted) | $0.82 | $0.70 | $1.23 | $-0.89 | $-0.60 |
Analyst forecast
ForecastConsensus (4 analysts)
strong_buy
Avg. price target
$36.33+41.91%
- Strong buy 1
- Buy 3
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 2, 2026
- EPS actual vs est.
- $0.31 vs $0.30
- Surprise
- +3.33%
TCMD news
All TCMD news- Tactile Medical to Participate in the Piper Sandler 38th Annual Healthcare ConferenceGlobeNewswire
- ISRG Agrees to $450M Settlement: What Does It Mean for Investors?NasdaqISRG, ABT, TCMD
- Tactile Systems: 3 Key Takeaways for Long-Term InvestorsNasdaq
- Tactile (TCMD) Q3 2026 Earnings Call TranscriptNasdaq
- Tactile Medical's Spending Outpaces Sales: Rapid Earnings ReactionNasdaq
- Tactile Systems Technology, Inc. Reports Third Quarter 2026 Financial ResultsGlobeNewswire
- Intuitive Surgical, Inc. (ISRG) Q3 Earnings and Revenues Top EstimatesNasdaqISRG, TCMD
- Tactile Medical to Release Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026GlobeNewswire
Tactile Systems Technology peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SGHTSight Sciences Inc. | 10.18 | -4.14% | $565.79M | vs TCMD |
| DCTHDelcath Systems Inc. | 18.79 | -2.34% | $653.67M | vs TCMD |
| RCELAvita Medical Inc. | 15.62 | -2.31% | $494.96M | vs TCMD |
| BVSBioventus Inc. Class A | 9.88 | -0.70% | $676.53M | vs TCMD |
| CARLCarlsmed Inc. | 17.42 | +1.16% | $477.38M | vs TCMD |
| ANGOAngioDynamics Inc. | 10.81 | +0.46% | $454.61M | vs TCMD |
| MDXGMiMedx Group Inc | 3.05 | -1.93% | $445.07M | vs TCMD |
| SENSSenseonics Holdings Inc. | 8.02 | -9.94% | $439.34M | vs TCMD |
Indexes, lists and sector
Tactile Systems Technology stock FAQ
What is Tactile Systems Technology's stock price today?
TCMD last traded at $25.60 as of Nov 20, 4:00 PM EST, down 1.50% on the day. Prices are delayed at least 15 minutes.
What is TCMD's P/E ratio?
TCMD trades at a trailing P/E ratio of 24.85 and a forward P/E of 17.41.
Who is Tactile Systems Technology's CEO?
Ms. Sheri Louise Dodd is the chief executive officer of Tactile Systems Technology Inc., which has about 1,086 employees.
What is the TCMD 52-week high?
The 52-week high for TCMD is $37.77 and the 52-week low is $20.53. The stock is currently 32.2% below its high.